Given the prominent role of TGF-β in inflammation and cell proliferation, and its targeting in PDR treatment, the study suggests a potential pathogenic role for miR-21 in diabetic retinopathy (108–110). This evidence concerns the gene TGFB1 and diabetic retinopathy.